CASI logo

CASI Pharmaceuticals (CASI) Net Income

Annual Net Income

-$26.94 M
+$14.08 M+34.32%

December 31, 2023

Summary

Performance

1-Year Change

+34.32%

3-Year Change

+44.21%

5-Year Change

+1.94%

15-Year Change

-150.12%

CASI Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

50.89%
CASI annual net profit is higher than 50.89% of companies in Healthcare sector

High & Low

All-time High

-$4.56 M

3-Year Low

-$41.01 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CASI previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 28, 2025
CASI next annual earnings announcement is scheduled for Mar 28, 2025

OtherCASIprofitabilitymetrics:

Annual Net Margin

-79.51%
CASI annual net profit margin is -79.51%

Annual Revenue

$33.88 M
CASI annual revenue is $33.88 million

Annual Gross Profit

$20.05 M
CASI annual gross profit is $20.05 million

Annual EPS

-$2.02
CASI annual earnings per share is -$2.02

Quarterly Net Income

-$8.39 M
-$1.43 M-20.53%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

CASI Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.5%
CASI quarterly net profit is higher than 44.5% of companies in Healthcare sector

High & Low

All-time High

$6.17 M
CASI quarterly net profit is currently -236.17% below its historical high of $6.17 million

3-Year Low

-$19.54 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CASI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CASI next earnings announcement is scheduled for Mar 28, 2025

OtherCASIprofitabilitymetrics:

Quarterly Net Margin

-107.72%
CASI quarterly net profit margin is -107.72%

Quarterly Revenue

$7.79 M
CASI quarterly revenue is $7.79 million

Quarterly Gross Profit

$4.04 M
CASI quarterly gross profit is $4.04 million

Quarterly EPS

-$0.55
CASI quarterly earnings per share is -$0.55

TTM Net Income

-$30.94 M
-$3.76 M-13.83%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

0%

5-Year Change

0%

CASI TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.97%
CASI TTM net profit is higher than 46.97% of companies in Healthcare sector

High & Low

All-time High

-$1.70 M

3-Year Low

-$41.01 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
CASI previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 28, 2025
CASI next earnings announcement is scheduled for Mar 28, 2025

OtherCASIprofitabilitymetrics:

Annual Net Margin

-79.51%
CASI annual net profit margin is -79.51%

TTM Revenue

$22.05 M
CASI TTM revenue is $22.05 million

TTM Gross Profit

$11.98 M
CASI TTM gross profit is $11.98 million

TTM EPS

-$2.24
CASI TTM earnings per share is -$2.24

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$26.94 M
CASI annual net profit is -$26.94 million

Annual Revenue

$33.88 M
CASI annual revenue is $33.88 million

Annual Cost Of Goods Sold

$13.83 M
CASI annual cost of goods sold is $13.83 million

Annual Operating Expenses

$45.33 M
CASI annual total operating expenses is $45.33 million

Annual Interest Expense

-
CASI annual interest expense value is unknown

Annual Income Tax

-$81.00 K
CASI annual income tax is -$81.00 thousand

CASI Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+34.3%0.0%0.0%
3 y3 years+44.2%0.0%0.0%
5 y5 years+1.9%0.0%0.0%

CASI Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+34.3%-81.1%+57.0%-14.9%+24.6%
5 y5-yearat high+44.2%-81.1%+57.0%-14.9%+42.4%
alltimeall time-490.9%+46.0%-236.2%+75.8%-1720.2%+49.7%

CASI Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
-$8.39 M(+20.5%)
-$30.94 M(+13.8%)
Jun 2024
-
-$6.96 M(-26.9%)
-$27.18 M(-10.7%)
Mar 2024
-
-$9.53 M(+57.4%)
-$30.46 M(+13.1%)
Dec 2023
-$26.94 M(-34.3%)
-$6.05 M(+30.6%)
-$26.94 M(-33.4%)
Sep 2023
-
-$4.63 M(-54.7%)
-$40.42 M(-1.4%)
Jun 2023
-
-$10.24 M(+70.4%)
-$40.99 M(+6.7%)
Mar 2023
-
-$6.01 M(-69.2%)
-$38.43 M(-6.3%)
Dec 2022
-$41.01 M(+11.9%)
-$19.54 M(+275.6%)
-$41.01 M(+51.5%)
Sep 2022
-
-$5.20 M(-32.3%)
-$27.08 M(-15.6%)
Jun 2022
-
-$7.68 M(-10.7%)
-$32.10 M(+2.3%)
Mar 2022
-
-$8.60 M(+53.5%)
-$31.37 M(-14.4%)
Dec 2021
-$36.65 M(-24.1%)
-$5.60 M(-45.2%)
-$36.65 M(-19.0%)
Sep 2021
-
-$10.22 M(+47.2%)
-$45.25 M(-12.9%)
Jun 2021
-
-$6.95 M(-50.0%)
-$51.98 M(-3.3%)
Mar 2021
-
-$13.88 M(-2.2%)
-$53.73 M(+11.3%)
Dec 2020
-$48.29 M(+4.9%)
-$14.20 M(-16.2%)
-$48.29 M(+3.7%)
Sep 2020
-
-$16.95 M(+95.0%)
-$46.58 M(+17.9%)
Jun 2020
-
-$8.69 M(+3.0%)
-$39.52 M(-14.6%)
Mar 2020
-
-$8.44 M(-32.4%)
-$46.30 M(+0.6%)
Dec 2019
-$46.03 M(+67.6%)
-$12.49 M(+26.3%)
-$46.03 M(+7.5%)
Sep 2019
-
-$9.89 M(-36.1%)
-$42.80 M(+2.7%)
Jun 2019
-
-$15.47 M(+89.2%)
-$41.67 M(+30.0%)
Mar 2019
-
-$8.18 M(-11.7%)
-$32.06 M(+16.7%)
Dec 2018
-$27.47 M(+155.1%)
-$9.26 M(+5.8%)
-$27.47 M(+18.1%)
Sep 2018
-
-$8.76 M(+49.4%)
-$23.25 M(+44.3%)
Jun 2018
-
-$5.86 M(+63.2%)
-$16.11 M(+27.3%)
Mar 2018
-
-$3.59 M(-28.9%)
-$12.66 M(+17.6%)
Dec 2017
-$10.77 M(+13.9%)
-$5.05 M(+212.9%)
-$10.77 M(+28.3%)
Sep 2017
-
-$1.61 M(-33.0%)
-$8.40 M(-0.9%)
Jun 2017
-
-$2.41 M(+41.7%)
-$8.48 M(-9.4%)
Mar 2017
-
-$1.70 M(-36.4%)
-$9.36 M(-1.0%)
Dec 2016
-$9.45 M(+31.2%)
-$2.67 M(+57.9%)
-$9.45 M(+11.4%)
Sep 2016
-
-$1.69 M(-48.6%)
-$8.48 M(+1.1%)
Jun 2016
-
-$3.29 M(+83.5%)
-$8.39 M(+16.6%)
Mar 2016
-
-$1.79 M(+5.4%)
-$7.20 M(-0.1%)
Dec 2015
-$7.21 M(-72.5%)
-$1.70 M(+6.1%)
-$7.21 M(+1.5%)
Sep 2015
-
-$1.60 M(-23.4%)
-$7.10 M(-73.7%)
Jun 2015
-
-$2.10 M(+16.2%)
-$27.03 M(+1.8%)
Mar 2015
-
-$1.80 M(+12.9%)
-$26.55 M(+1.3%)
Dec 2014
-$26.20 M(+356.6%)
-$1.60 M(-92.6%)
-$26.20 M(+1.1%)
Sep 2014
-
-$21.54 M(+1232.6%)
-$25.91 M(+345.4%)
Jun 2014
-
-$1.62 M(+11.4%)
-$5.82 M(-3.9%)
Mar 2014
-
-$1.45 M(+10.9%)
-$6.05 M(+5.5%)
Dec 2013
-$5.74 M(-60.5%)
-$1.31 M(-9.3%)
-$5.74 M(+19.8%)
Sep 2013
-
-$1.44 M(-22.1%)
-$4.79 M(+5.6%)
Jun 2013
-
-$1.85 M(+63.0%)
-$4.54 M(-65.5%)
Mar 2013
-
-$1.14 M(+215.2%)
-$13.15 M(-9.6%)
Dec 2012
-$14.55 M(+219.1%)
-$360.40 K(-69.7%)
-$14.55 M(+10.4%)
Sep 2012
-
-$1.19 M(-88.6%)
-$13.18 M(-0.9%)
Jun 2012
-
-$10.46 M(+312.9%)
-$13.30 M(+195.8%)
Mar 2012
-
-$2.53 M(-352.3%)
-$4.50 M(-1.4%)
Dec 2011
-$4.56 M(-43.7%)
$1.00 M(-176.8%)
-$4.56 M(+1.3%)
Sep 2011
-
-$1.31 M(-21.1%)
-$4.50 M(-14.9%)
Jun 2011
-
-$1.66 M(-36.1%)
-$5.29 M(-38.3%)
Mar 2011
-
-$2.60 M(-343.8%)
-$8.57 M(+5.8%)
Dec 2010
-$8.10 M
$1.06 M(-150.8%)
-$8.10 M(-25.7%)
Sep 2010
-
-$2.10 M(-57.6%)
-$10.90 M(+25.0%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$4.94 M(+132.6%)
-$8.72 M(+27.7%)
Mar 2010
-
-$2.13 M(+22.7%)
-$6.83 M(-16.9%)
Dec 2009
-$8.22 M(-65.6%)
-$1.73 M(-2141.6%)
-$8.22 M(-9.0%)
Sep 2009
-
$84.90 K(-102.8%)
-$9.03 M(-27.8%)
Jun 2009
-
-$3.05 M(-13.2%)
-$12.51 M(-34.3%)
Mar 2009
-
-$3.52 M(+38.0%)
-$19.03 M(-20.2%)
Dec 2008
-$23.86 M(+6.5%)
-$2.55 M(-25.0%)
-$23.86 M(-4.9%)
Sep 2008
-
-$3.40 M(-64.5%)
-$25.08 M(+1.5%)
Jun 2008
-
-$9.57 M(+14.7%)
-$24.72 M(+7.1%)
Mar 2008
-
-$8.35 M(+121.5%)
-$23.08 M(+3.0%)
Dec 2007
-$22.41 M(-55.1%)
-$3.77 M(+24.1%)
-$22.41 M(-7.7%)
Sep 2007
-
-$3.04 M(-61.7%)
-$24.27 M(-2.0%)
Jun 2007
-
-$7.93 M(+3.4%)
-$24.76 M(+8.4%)
Mar 2007
-
-$7.67 M(+36.4%)
-$22.85 M(-54.2%)
Dec 2006
-$49.89 M(+205.8%)
-$5.63 M(+59.6%)
-$49.89 M(+7.4%)
Sep 2006
-
-$3.52 M(-41.5%)
-$46.44 M(-1.8%)
Jun 2006
-
-$6.03 M(-82.6%)
-$47.29 M(+3.8%)
Mar 2006
-
-$34.71 M(+1494.6%)
-$45.57 M(+179.3%)
Dec 2005
-$16.31 M(+29.2%)
-$2.18 M(-50.3%)
-$16.31 M(+13.3%)
Sep 2005
-
-$4.38 M(+1.9%)
-$14.40 M(+9.4%)
Jun 2005
-
-$4.30 M(-21.2%)
-$13.16 M(+0.4%)
Mar 2005
-
-$5.46 M(+1998.7%)
-$13.11 M(+3.9%)
Dec 2004
-$12.62 M(-35.3%)
-$260.00 K(-91.7%)
-$12.62 M(-31.1%)
Sep 2004
-
-$3.15 M(-25.9%)
-$18.31 M(-7.3%)
Jun 2004
-
-$4.25 M(-14.5%)
-$19.76 M(-4.9%)
Mar 2004
-
-$4.97 M(-16.5%)
-$20.77 M(+6.5%)
Dec 2003
-$19.49 M(-50.0%)
-$5.95 M(+29.4%)
-$19.49 M(+29.5%)
Sep 2003
-
-$4.60 M(-12.6%)
-$15.05 M(-32.2%)
Jun 2003
-
-$5.26 M(+42.5%)
-$22.21 M(-21.3%)
Mar 2003
-
-$3.69 M(+145.2%)
-$28.20 M(-27.7%)
Dec 2002
-$39.02 M(-9.9%)
-$1.50 M(-87.2%)
-$39.02 M(-36.6%)
Sep 2002
-
-$11.75 M(+4.4%)
-$61.52 M(+41.1%)
Jun 2002
-
-$11.25 M(-22.5%)
-$43.60 M(-7.7%)
Mar 2002
-
-$14.51 M(-39.5%)
-$47.23 M(+9.1%)
Dec 2001
-$43.31 M(-11.2%)
-$24.00 M(-489.3%)
-$43.31 M(+31.1%)
Sep 2001
-
$6.17 M(-141.4%)
-$33.04 M(-34.6%)
Jun 2001
-
-$14.88 M(+40.4%)
-$50.49 M(+3.6%)
Mar 2001
-
-$10.59 M(-22.9%)
-$48.75 M(-0.1%)
Dec 2000
-$48.79 M(+32.2%)
-$13.74 M(+21.8%)
-$48.79 M(-2.1%)
Sep 2000
-
-$11.28 M(-14.1%)
-$49.86 M(+9.6%)
Jun 2000
-
-$13.13 M(+23.4%)
-$45.48 M(+12.7%)
Mar 2000
-
-$10.64 M(-28.1%)
-$40.35 M(+9.5%)
Dec 1999
-$36.90 M(+173.3%)
-$14.80 M(+114.5%)
-$36.86 M(+38.3%)
Sep 1999
-
-$6.90 M(-13.8%)
-$26.66 M(+12.2%)
Jun 1999
-
-$8.01 M(+12.0%)
-$23.76 M(+35.4%)
Mar 1999
-
-$7.15 M(+55.4%)
-$17.55 M(+30.0%)
Dec 1998
-$13.50 M(+107.7%)
-$4.60 M(+15.0%)
-$13.50 M(+22.7%)
Sep 1998
-
-$4.00 M(+122.2%)
-$11.00 M(+25.0%)
Jun 1998
-
-$1.80 M(-41.9%)
-$8.80 M(+7.3%)
Mar 1998
-
-$3.10 M(+47.6%)
-$8.20 M(+26.2%)
Dec 1997
-$6.50 M(+35.4%)
-$2.10 M(+16.7%)
-$6.50 M(+14.0%)
Sep 1997
-
-$1.80 M(+50.0%)
-$5.70 M(+7.5%)
Jun 1997
-
-$1.20 M(-14.3%)
-$5.30 M(+15.2%)
Mar 1997
-
-$1.40 M(+7.7%)
-$4.60 M(-6.1%)
Dec 1996
-$4.80 M
-$1.30 M(-7.1%)
-$4.90 M(+36.1%)
Sep 1996
-
-$1.40 M(+180.0%)
-$3.60 M(+63.6%)
Jun 1996
-
-$500.00 K(-70.6%)
-$2.20 M(+29.4%)
Mar 1996
-
-$1.70 M
-$1.70 M

FAQ

  • What is CASI Pharmaceuticals annual net profit?
  • What is the all time high annual net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals annual net income year-on-year change?
  • What is CASI Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals quarterly net income year-on-year change?
  • What is CASI Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for CASI Pharmaceuticals?
  • What is CASI Pharmaceuticals TTM net income year-on-year change?

What is CASI Pharmaceuticals annual net profit?

The current annual net income of CASI is -$26.94 M

What is the all time high annual net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high annual net profit is -$4.56 M

What is CASI Pharmaceuticals annual net income year-on-year change?

Over the past year, CASI annual net profit has changed by +$14.08 M (+34.32%)

What is CASI Pharmaceuticals quarterly net profit?

The current quarterly net income of CASI is -$8.39 M

What is the all time high quarterly net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high quarterly net profit is $6.17 M

What is CASI Pharmaceuticals quarterly net income year-on-year change?

Over the past year, CASI quarterly net profit has changed by $0.00 (0.00%)

What is CASI Pharmaceuticals TTM net profit?

The current TTM net income of CASI is -$30.94 M

What is the all time high TTM net income for CASI Pharmaceuticals?

CASI Pharmaceuticals all-time high TTM net profit is -$1.70 M

What is CASI Pharmaceuticals TTM net income year-on-year change?

Over the past year, CASI TTM net profit has changed by $0.00 (0.00%)